Raymond James Financial’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Sell
79,891
-593,663
-88% -$13.1M ﹤0.01% 3630
2026
Q1
$15.9M Sell
673,554
-51,350
-7% -$1.6M ﹤0.01% 1633
2025
Q4
$32.3M Sell
724,904
-80,108
-10% -$4.5M 0.01% 1111
2025
Q3
$58.9M Buy
805,012
+279,761
+53% +$18.2M 0.02% 712
2025
Q2
$32.2M Buy
525,251
+330,442
+170% +$18.4M 0.01% 1043
2025
Q1
$11.3M Buy
194,809
+20,717
+12% +$1.31M ﹤0.01% 1711
2024
Q4
$9.29M Buy
+174,092
New +$8.52M ﹤0.01% 1914

Other funds holding DOCS

Raymond James Financial's DOCS Position: Q2 2026 in Review

Raymond James Financial reduced its Doximity (DOCS) stake by 88% in Q2 2026, selling an estimated $13.1M and leaving 79,891 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #3630.

Raymond James Financial first reported a position in DOCS in Q4 2024 and has held it in 7 quarters since. The position peaked at $58.9M in Q3 2025. 359 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Raymond James Financial held 79,891 shares of Doximity worth $1.66M as of Q2 2026.
  • Raymond James Financial sold 593,663 Doximity shares in Q2 2026, an estimated $13.1M.
  • Doximity made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3630 holding.
  • Raymond James Financial first reported a position in Doximity in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Doximity position peaked at $58.9M in Q3 2025.
  • 359 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.